title: Receptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew (Cryptotis parva).
abstract: Research on the mechanisms of emesis has implicated multiple neurotransmitters via both central (dorsal vagal complex) and peripheral (enteric neurons and enterochromaffin cells) anatomical substrates. Taking advantage of advances in receptor-specific agonists, and utilizing Fos expression as a functional activity marker, this study demonstrates a strong, but incomplete, overlap in anatomical substrates for a variety of emetogens. We used cisplatin and specific agonists to 5-HT(3) serotonergic, D(2)/D(3) dopaminergic, and NK(1) tachykininergic receptors to induce vomiting in the least shrew (Cryptotis parva), and quantified the resulting Fos expression. The least shrew is a small mammal whose responses to emetic challenges are very similar to its human counterparts. In all cases, the enteric nervous system, nucleus of the solitary tract, and dorsal motor nucleus of the vagus demonstrated significantly increased Fos immunoreactivity (Fos-IR). However, Fos-IR induction was notably absent from the area postrema following the dopaminergic and NK(1) receptor-specific agents. Two brain nuclei not usually discussed regarding emesis, the dorsal raphe nucleus and paraventricular thalamic nucleus, also demonstrated increased emesis-related Fos-IR. Taken together, these data suggest the dorsal vagal complex is part of a common pathway for a variety of distinct emetogens, but there are central emetic substrates, both medullary and diencephalic, that can be accessed without directly stimulating the area postrema.
authors.affiliation: Department of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766-1854, USA.
authors.forename: Andrew P
authors.initials: AP
authors.lastname: Ray
authors.forename: Seetha
authors.initials: S
authors.lastname: Chebolu
authors.forename: Nissar A
authors.initials: NA
authors.lastname: Darmani
mesh_terms: D000223:Adaptation, Psychological; D000818:Animals; D001921:Brain / Q000166:cytology / Q000378:metabolism*; D001933:Brain Stem / Q000166:cytology / Q000378:metabolism; D004639:Emetics / Q000008:administration & dosage / Q000494:pharmacology*; D017615:Enteric Nervous System / Q000166:cytology / Q000378:metabolism*; D005260:Female; D007274:Injections, Intraperitoneal; D009474:Neurons / Q000378:metabolism*; D010477:Perfusion; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism; D012788:Shrews; D017552:Solitary Nucleus / Q000166:cytology / Q000378:metabolism; D013373:Substance P / Q000378:metabolism; D013997:Time Factors; D014630:Vagus Nerve / Q000166:cytology / Q000378:metabolism; D014839:Vomiting / Q000139:chemically induced* / Q000517:prevention & control
chemical_list: D004639:Emetics; D016760:Proto-Oncogene Proteins c-fos; D012701:Serotonin; D013373:Substance P
references.citation: Neuroscience. 1999;94(2):663-73
references.pmid: 10579226
references.citation: Annu Rev Physiol. 2006;68:279-305
references.pmid: 16460274
references.citation: Neuropharmacology. 2006 Oct;51(5):974-85
references.pmid: 16901513
references.citation: J Oncol Pharm Pract. 2006 Dec;12(4):201-9
references.pmid: 17156592
references.citation: Brain Res. 2007 Jul 2;1156:99-111
references.pmid: 17540350
references.citation: Auton Neurosci. 2003 Aug 29;107(1):1-8
references.pmid: 12927221
references.citation: Eur J Pharmacol. 2002 Oct 25;453(2-3):299-308
references.pmid: 12398918
references.citation: J Neurosci. 2002 Sep 1;22(17):7730-6
references.pmid: 12196596
references.citation: Toxicology. 2000 Nov 16;153(1-3):189-201
references.pmid: 11090957
references.citation: J Pharmacol Exp Ther. 2000 Apr;293(1):214-21
references.pmid: 10734172
references.citation: J Neurosci. 1992 Jan;12(1):235-48
references.pmid: 1729436
references.citation: J Neurosci. 1994 Feb;14(2):871-88
references.pmid: 8301366
references.citation: J Pharmacol Exp Ther. 1992 Aug;262(2):855-65
references.pmid: 1354257
references.citation: Eur J Neurosci. 2007 May;25(9):2773-82
references.pmid: 17459108
references.citation: Neuropharmacology. 1992 Aug;31(8):735-42
references.pmid: 1326727
references.citation: Drugs. 1997 Feb;53(2):206-34
references.pmid: 9028742
references.citation: Pharmacol Biochem Behav. 2005 Jan;80(1):35-44
references.pmid: 15652378
references.citation: Q J Exp Physiol. 1988 Jan;73(1):7-21
references.pmid: 3347698
references.citation: J Comp Neurol. 1995 Aug 21;359(2):221-38
references.pmid: 7499526
references.citation: Brain Res. 1988 Feb 9;440(2):252-60
references.pmid: 3129127
references.citation: Neurosci Res. 1992 Aug;14(3):180-94
references.pmid: 1331922
references.citation: J Neural Transm (Vienna). 1999;106(11-12):1045-61
references.pmid: 10651102
references.citation: Nature. 1987 Aug 13-19;328(6131):632-4
references.pmid: 3112583
references.citation: Neuropsychopharmacology. 2003 Feb;28(2):206-15
references.pmid: 12589373
references.citation: Brain Res. 1978 Sep 15;153(1):1-26
references.pmid: 679038
references.citation: Am J Physiol. 1994 Apr;266(4 Pt 2):R1118-26
references.pmid: 8184953
references.citation: Auton Neurosci. 2007 Mar 30;132(1-2):44-51
references.pmid: 17092780
references.citation: Neurobiology (Bp). 1993;1(4):337-50
references.pmid: 8069291
references.citation: Gastroenterology. 1952 Sep;22(1):1-12
references.pmid: 12980223
references.citation: Mol Pharmacol. 2008 Feb;73(2):314-22
references.pmid: 17993512
references.citation: Neuropharmacology. 2000 Jan 4;39(2):316-23
references.pmid: 10670427
references.citation: Exp Anim. 2002 Jan;51(1):19-25
references.pmid: 11871148
references.citation: J Comp Neurol. 1987 Nov 8;265(2):175-88
references.pmid: 3320108
references.citation: J Neural Transm (Vienna). 1998;105(10-12):1143-54
references.pmid: 9928884
references.citation: J Pharmacol Exp Ther. 2002 Jan;300(1):34-42
references.pmid: 11752094
references.citation: Eur J Cancer. 2003 May;39(8):1074-80
references.pmid: 12736106
references.citation: Brain Res. 2009 Jan 12;1248:40-58
references.pmid: 19022231
references.citation: Anesthesiology. 2001 May;94(5):882-7
references.pmid: 11388542
references.citation: Mol Pharmacol. 2007 Dec;72(6):1411-8
references.pmid: 17890358
references.citation: Br J Cancer. 1992 Jul;66(1):198-203
references.pmid: 1379060
references.citation: Eur J Pharmacol. 1996 Apr 22;301(1-3):143-9
references.pmid: 8773458
references.citation: Am J Med. 2000 Mar 6;108 Suppl 4a:90S-98S
references.pmid: 10718459
references.citation: J Pharmacol Exp Ther. 1992 Feb;260(2):509-17
references.pmid: 1738101
references.citation: Pharmacol Ther. 2003 Aug;99(2):149-65
references.pmid: 12888110
references.citation: Brain Res. 1998 Mar 23;787(2):304-10
references.pmid: 9518661
references.citation: Neurosci Res. 1992 Aug;14(3):166-79
references.pmid: 1331921
references.citation: Ann N Y Acad Sci. 1989;568:283-90
references.pmid: 2516994
references.citation: Anat Rec. 2001 Jan 1;262(1):29-40
references.pmid: 11146426
references.citation: Brain Res. 2004 Aug 13;1017(1-2):208-17
references.pmid: 15261116
references.citation: Support Care Cancer. 1997 May;5(3):212-8
references.pmid: 9176967
references.citation: Br J Pharmacol. 1989 May;97(1):247-55
references.pmid: 2720310
references.citation: Science. 1988 Jun 3;240(4857):1328-31
references.pmid: 3131879
references.citation: J Pharmacol Toxicol Methods. 1994 Oct;32(2):109-16
references.pmid: 7865862
references.citation: Exp Brain Res. 1998 Jan;118(2):139-47
references.pmid: 9547082
references.citation: Neurosci Res. 1999 Jan;33(1):25-32
references.pmid: 10096468
references.citation: Neuropharmacology. 1993 Oct;32(10):959-68
references.pmid: 8295718
references.citation: Brain Res. 1994 Jun 6;647(2):255-64
references.pmid: 7922502
references.citation: Br J Anaesth. 1992;69(7 Suppl 1):2S-19S
references.pmid: 1486009
references.citation: Synapse. 1996 Nov;24(3):224-32
references.pmid: 8923662
references.citation: Eur J Pharmacol. 2004 Mar 19;488(1-3):201-12
references.pmid: 15044052
references.citation: Am J Physiol Gastrointest Liver Physiol. 2003 Sep;285(3):G566-76
references.pmid: 12791597
references.citation: J Comp Neurol. 2002 May 20;447(1):82-97
references.pmid: 11967897
references.citation: Brain Res. 1991 Nov 29;565(2):231-6
references.pmid: 1668810
references.citation: J Neurosci Methods. 1989 Sep;29(3):261-5
references.pmid: 2507830
references.citation: Eur J Pharmacol. 2003 Jul 4;472(1-2):135-45
references.pmid: 12860482
references.citation: Neuropharmacology. 2005 Sep;49(4):502-13
references.pmid: 15921709
references.citation: Behav Brain Res. 2009 Jan 3;196(1):30-6
references.pmid: 18721829
references.citation: Neurogastroenterol Motil. 1996 Sep;8(3):255-72
references.pmid: 8878086
references.citation: Br J Pharmacol. 1995 May;115(1):84-94
references.pmid: 7544198
references.citation: Regul Pept. 2001 Apr 2;98(1-2):55-62
references.pmid: 11179779
references.citation: Brain Res. 2008 Jun 12;1214:58-72
references.pmid: 18471804
references.citation: Eur J Pharmacol. 2004 Jan 26;484(2-3):311-21
references.pmid: 14744618
references.citation: Am J Med. 2001 Dec 3;111 Suppl 8A:106S-112S
references.pmid: 11749934
references.citation: J Comp Neurol. 1987 Nov 8;265(2):275-93
references.pmid: 2447131
references.citation: Chem Rev. 2009 Jul;109(7):3158-99
references.pmid: 19522506
references.citation: J Neurosci. 2003 Aug 6;23(18):7155-9
references.pmid: 12904475
references.citation: Auton Neurosci. 2007 Oct 30;136(1-2):20-30
references.pmid: 17478125